Host-Directed Small Molecules, Peptides, and Anticoagulant/Anti-NET Agents

Commercial sector

Host-Directed Small Molecules, Peptides, and Anticoagulant/Anti-NET Agents

Companies developing small-molecule drugs, therapeutic peptides, aptamers, or anticoagulant/anti-NET agents for sepsis that target host pathways such as inflammasomes, kinases, coagulation, vascular leak, or oxidative stress, including lipid and nanoparticle scavengers.

Companies18
Commercial products33
Technology classes1
Countries8
Patents147

Profiled companies

Products
  • Vivacelle Bio logo
    Vivacelle Bio
    United States2
  • Matisse Pharmaceuticals B.V. logo
    Matisse Pharmaceuticals B.V.
    Netherlands4
  • Abionyx Pharma logo
    Abionyx Pharma
    France1
  • Aptahem logo
    Aptahem
    Sweden3
  • Arch Biopartners logo
    Arch Biopartners
    Canada3
  • Endacea logo
    Endacea
    United States1

+ 12 more

← Back to what’s inside this report